Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
about
Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cellsPDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisRestrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.PDE4B as a microglia target to reduce neuroinflammation.Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.The role of sildenafil in the development of transplant arteriosclerosis in rat aortic grafts.Propentofylline, phosphodiesterase and adenosine reuptake inhibitor modulates lymphocyte subsets and lymphocyte activity after in-vivo administration in non-immunized and SRBC-immunized mice.Roflumilast Reduces Cerebral Inflammation in a Rat Model of Experimental Subarachnoid Hemorrhage.
P2860
Q33624262-E9E7B2FF-B3D6-4BE9-ABA5-6E375DDA2CB2Q34156231-839967AA-6891-476B-9920-CFD76231F09EQ36016406-B995E35D-7489-4088-BE16-25983040111AQ36700629-EACEC671-3F62-443A-A471-77FE2015D3E4Q37657490-892742EE-16FA-4A8C-980D-8C11D3686C78Q38256936-0DEF0A8F-C8A7-4D28-B06B-55FB8D20C0BAQ38653998-A1909259-4F19-497F-8CEA-EC6CD15223AAQ38796315-0DAECDC3-1C04-4808-9392-116E1D29B01CQ41975587-96FECEA5-7952-4E51-B03B-9F4A43D54C83Q47154544-508C84E5-8A15-4937-9DC2-ADDD95A48D5CQ48268233-8E00C085-03F6-41EE-8E3B-D6BDD8C2414DQ50177500-B079157A-CCC2-4C85-A58E-9518AC2EDA57
P2860
Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@en
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@nl
type
label
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@en
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@nl
prefLabel
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@en
Comparative assessment of PDE ...... autoimmune encephalomyelitis.
@nl
P2093
P2860
P356
P1476
Comparative assessment of PDE ...... l autoimmune encephalomyelitis
@en
P2093
A Ballester
C González-García
R Gómez-Pérez
S Ballester
P2860
P304
P356
10.1111/BPH.12308
P407
P577
2013-10-01T00:00:00Z